XELOX for Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Capecitabine and Oxaliplatin
Sponsor: University of Wisconsin, Madison
Collaborators: Sanofi